SKAN Group AG (FRA:7VG) Total Operating Expense: €247.2 Mil (TTM As of Dec. 2025)


FRA:7VG SKAN Group AG FRA:7VG
62 GF Score
Price €59.00
GF Value €90.87
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is SKAN Group AG Total Operating Expense?

SKAN Group AG FRA:7VG +2.61% 62 Total Operating Expense is €247.2 Mil as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review.

SKAN Group AG's Total Operating Expense for the six months ended in Dec. 2025 was €127.4 Mil. SKAN Group AG's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €247.2 Mil.

SKAN Group AG Total Operating Expense Related Terms

SKAN Group AG Total Operating Expense Historical Data

* Premium members only.

The historical data trend for SKAN Group AG's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG Total Operating Expense Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 141.31 173.31 215.06 237.14 247.77

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 109.48 115.39 118.23 119.72 127.44
FRA:7VG
62GF Score
SKAN Group AG FRA:7VG
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SKAN Group AG Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €247.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €247.2 Mil mean?
SKAN Group AG (FRA:7VG) has a Total Operating Expense of €247.2 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on SKAN Group AG and its competitors.
Is SKAN Group AG's Total Operating Expense too high?
SKAN Group AG's current Total Operating Expense is €247.2 Mil. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Total Operating Expense compare to ISRG and BDX?
SKAN Group AG's Total Operating Expense of €247.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on SKAN Group AG and its competitors. SKAN Group AG's current Total Operating Expense is €247.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current Total Operating Expense is €247.2 Mil. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Total Operating Expense is €247.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SKAN Group AG (FRA:7VG) Overvalued in 2026?

Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued. The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87. GuruFocus considers SKAN Group AG to be Significantly Undervalued.

Key valuation signals for FRA:7VG:

  • Total Operating Expense: €247.2 Mil
  • GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SKAN Group AG Business Description

Address Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score

Get the complete analysis for FRA:7VG

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.00
Price
€90.87
GF Value